TP53 and neoplasm: To evaluate the steady state interaction between cisplatin, oxidative stress and tumor metabolism we generated conditioned cisplatin resistance (>5-fold increase in IC50) in HN30, a wild-type TP53 expressing, cisplatin sensitive HNSCC cell line (Figure 2A) [12,13,30].